Scroll through any public health website, search for diabetes, and you’ll quickly discover a multitude of confronting facts: number 6 of non-communicable diseases causing death; 422 million people affected worldwide; prevalence of both type-1 and type-2 diabetes among children and adolescents increases, to highlight a few.
Diabetes has an inescapable effect on our society, including our health systems, economies and most importantly, on people with diabetes and their families. Doctors, nurses, educators, health promoters and policymakers are all involved in diabetes care, so we’ve assembled our picks of some of the top international diabetes journals to help health professionals stay up-to-date with the latest research and news.
Impact factor: is based on Web of Science data and only includes documents such as articles and reviews. It measures the average number of times an article is cited by other journal articles and documents. An impact factor of 3 or more is considered good, 1 is average. This list uses the 2-year impact factor from SCImago.
CiteScore: is based on Scopus data for all indexed documents, including articles, letters and editorials. Like impact factor, it measures the average citations received per document published in a journal over a 4-year time period.
Impact factor and CiteScore have the most meaning when used to compare journals within the same therapeutic area of subject. Many academics value a journal’s impact factor over its Citescore; therefore they will use the impact factor to rank other journals in the same field.
SCImago Journal Rank (SJR): measures the citations received from a journal but it also considers the importance of the journal where the citations have come from. This measurement can be helpful to rank journals within the same field and category.
Source Normalized Impact per Paper (SNIP): measures citations weighted by subject field. A SNIP over 1.0 means a journal has more citations than average.
Impact Factor: 27.576
The Lancet Diabetes and Endocrinology journal is published monthly and includes a range of original content related to diabetes and associated co-morbidities. The journal has a strong focus on publishing studies particularly relevant for low- and middle-income countries.
Impact Factor: 16.283
Nature Review Endocrinology is published by Nature Publishing Group. Published monthly, the journal includes research, news and reviews related to all fields of endocrinology and recent issues include discussions about insulin sensitivity and resistance, diabetic retinopathy and type-1 diabetes.
Impact Factor: 14.414
Published by the American Diabetes Association, the journal is aimed at all health professionals working with people with diabetes. It’s published monthly and in addition to featuring human research it also includes opinion pieces, letters to the editor and consensus reports.
Impact Factor: 12.413
This bi-monthly journal has a broad endocrinology focus; recent issues include diabetes-related research such as the mechanism of metformin, and the pathophysiology and clinical implications for diabetes, obesity and cancer.
Impact Factor: 7.778
The Diabetologia is a monthly journal from the European Association for the Study of Diabetes. It offers free, online access to all its journals 12 months following publication. Diabetologia includes content related to diabetes research and aims to advance the field of diabetes knowledge and care.
Impact Factor: 7.185
Like the name suggests, Cardiovascular Diabetology publishes a range of open access articles specifically focused on the link between diabetes and heart conditions. Recent articles include the impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19, the impact of fasting glucose and heart failure, and the risk of heart disease for people with diabetes and chronic kidney disease.
Impact Factor: 6.830
Diabetes is another journal by the American Diabetes Association and focuses on publishing content related to diabetes physiology and pathophysiology. Each monthly issue includes some open access articles.
Impact Factor: 6.092
Diabetes, Obesity and Metabolism (DOM) provides open or free access to its content, which focuses on research that will impact patient care. In 2020, it launched DOM NOW, which provides bite-sized information about the latest findings published in the journal, which health professionals can use to inform and improve patient care.
Impact Factor: 5.033
Diabetes Technology and Therapeutics is a peer-reviewed journal centred on the practical management of diabetes using medications, devices and drug-delivery systems. Health professionals working directly with people with diabetes will find this journal particularly relevant. Recent articles include how ethnicity impacts the use of technology for people with type-1 diabetes and the impact of telehealth during COVID-19. Some of its articles are open access.
Educating people to manage diabetes and minimise other co-morbidities means crafting the right message for your audience. At Rx Communications, we help organisations deliver patient-centric information to inspire behaviour change. Get in touch to see how we can help you connect with your patients.